EUVIMEDEUVIMED entdecken
Open Access

Arbutin overcomes tumor immune tolerance by inhibiting tumor programmed cell death-ligand 1 expression

Ching-Han Liu, Jing-Ru Weng, Li-Hsien Wu, Rui-Yang Song, Ming-Der Huang, Xin-He Wu, Chia C Wang, Che-Hsin Lee

International Journal of Medical Sciences · 2024

DOI: 10.7150/ijms.92419 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Medical Sciences, 2024. Verfasst von Ching-Han Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Internal Medicine, Kaohsiung Armed Forces General Hospital, Kaohsiung, Taiwan. Hauptthemen laut MEDLINE: B7-H1 Antigen, Arbutin, TOR Serine-Threonine Kinases, Proto-Oncogene Proteins c-akt. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

B7-H1 AntigenArbutinTOR Serine-Threonine KinasesProto-Oncogene Proteins c-aktSignal TransductionHumansCell Line, TumorImmune ToleranceNeoplasmsAnimalsGene Expression Regulation, NeoplasticMiceImmunotherapy

Stichwörter der Autor:innen

Arbutinprogrammed cell death protein ligand-1tumor immune tolerance

Substanzen

B7-H1 AntigenArbutinTOR Serine-Threonine KinasesCD274 protein, humanProto-Oncogene Proteins c-aktMTOR protein, human

Autor:innen und Institutionen

  • Division of Cardiology, Department of Internal Medicine, Kaohsiung Armed Forces General Hospital, Kaohsiung, Taiwan.
  • Department of Marine Biotechnology and Resources, National Sun Yat-sen University, Kaohsiung 80424, Taiwan.
  • Department of Biological Sciences, National Sun Yat-sen University, Kaohsiung, Taiwan.
  • Aerosol Science Research Center, National Sun Yat-sen University, Kaohsiung, Taiwan.
  • Department of Chemistry, National Sun Yat-sen University, Kaohsiung 80424, Taiwan.
  • College of semiconductor and advanced technology Research, National Sun Yat-sen University, Kaohsiung 80424, Taiwan.

Zitieren

APA

Liu, C. H., Weng, J. R., Wu, L. H., Song, R. Y., Huang, M. D., Wu, X. H., Wang, C. C., & Lee, C. H. (2024). Arbutin overcomes tumor immune tolerance by inhibiting tumor programmed cell death-ligand 1 expression. International Journal of Medical Sciences. https://doi.org/10.7150/ijms.92419

Vancouver

Liu CH, Weng JR, Wu LH, Song RY, Huang MD, Wu XH, et al. Arbutin overcomes tumor immune tolerance by inhibiting tumor programmed cell death-ligand 1 expression. International Journal of Medical Sciences. 2024. doi:10.7150/ijms.92419

BibTeX
@article{Liu2024,
  author = {Liu, Ching-Han and Weng, Jing-Ru and Wu, Li-Hsien and Song, Rui-Yang and Huang, Ming-Der and Wu, Xin-He and Wang, Chia C and Lee, Che-Hsin},
  title = {Arbutin overcomes tumor immune tolerance by inhibiting tumor programmed cell death-ligand 1 expression},
  journal = {International Journal of Medical Sciences},
  year = {2024},
  doi = {10.7150/ijms.92419}
}
Kostenlos starten →